
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Cronos Group (NASDAQ:CRON) through any online brokerage.
Other companies in Cronos Group’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Cronos Group has a consensus price target of $3.00.
The stock price for Cronos Group (NASDAQ: CRON) is $3.23 last updated October 9, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Cronos Group.
Cronos Group does not have any upcoming earnings scheduled.
There is no upcoming split for Cronos Group.
Cronos Group is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Cronos Group Inc is a cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology, and product development. With a passion for responsibly elevating the consumer experience, the company is...